Trevi Therapeutics
TRVI
TRVI
20 hedge funds and large institutions have $45.9M invested in Trevi Therapeutics in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PCM
Pinz Capital Management
New York
|
-$377K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$359K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$228K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$35.6K |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$25.1K |
